- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2017–2022 · career development · K08
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancer
Kent W Mouw · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers
Jinbo Chen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · fellowship · F32
Characterization of genetic modifiers of bioenergetic rescue in mitochondrial disease cell lines
Christopher F. Bennett · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K99
The PI3K/AKT Pathway Regulates Histone H3 Modification
Jennifer Marie Spangle · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
Kimmie Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2027 · research · R01
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase
Eric Sebastian Fischer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss
Matthew Gilbert Oser · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2024 · research · R25
Summer Program to Advance Research Careers (SPARC)
Edward J Benz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · cooperative agreement · UG1
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Improving Hospice Use for Patients with Blood Cancers
Oreofe Olukemi Odejide · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017 · prize · Warren Alpert Foundation Prize
Warren Alpert Foundation Prize 2017 - Gordon Freeman
Gordon Freeman · Dana-Farber Cancer Institute · funded by Warren Alpert Foundation
2017–2021 · cooperative agreement · UG1
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Prevention of HIV-1 transmission by small-molecule CD4-mimetic entry inhibitors
Navid Madani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · cooperative agreement · UG1
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Investigating 53BP1 'dephosphorylation' as a critical determinant of PARP
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
Eric Sebastian Fischer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia
Mark A. Murakami · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K99
Investigating the role of KLF5 genomic alterations in tumorigenesis
Xiaoyang Zhang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · fellowship · Scientist Development Grant
Determining mechanisms of redox control over adaptation to exercise
Edward Chouchani · Dana-Farber Cancer Institute · funded by American Heart Association
2017–2022 · career development · K08
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
Andrew James Aguirre · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · grant · PRCRP
Cyclin E1 in Gastric Cancer
Ankur Nagaraja · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2017–2022 · research · R01
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
Lili Wang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss
Matthew Gilbert Oser · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R50
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases
Eunyoung Park · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Metabolic and Bioenergetic Control in Mitochondrial Diseases
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
MYB family alterations in pediatric gliomas
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · program · P01
Human Cancer Suppressor Functions of Protein Phosphatase 2A
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
Eric Sebastian Fischer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R25
Summer Program to Advance Research Careers (SPARC)
Edward J Benz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancer
Kent W Mouw · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia
Mark A. Murakami · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India
Glorian C Sorensen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R33
Reducing viral reservoirs by opening HIV-1 Env to antibody attack
Joseph G Sodroski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · research · R21
Development of molecular probes to investigate and drug the oncogenic Wnt/?-catenin/BCL9/B9L transcriptional complex
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Exonizaton of Alu Insertion Polymorphisms
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K99
Inflammation, Physical Activity, and Colon Cancer Recurrence and Survival
Justin C Brown · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · program · P01
Human Cancer Suppressor Functions of Protein Phosphatase 2A
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · grant · ALSRP
Microglia-Targeted MRI/PET Traceable Nanovectors: Theranostic Platform for Tracking and Shaping Microglia Reactivity to Improve ALS Therapy
Marco Peviani · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2017–2022 · career development · K08
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
Andrew James Aguirre · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K08
Dissecting mechanisms of immunotherapy resistance in melanoma patients
Benjamin Izar · Dana-Farber Cancer Institute · funded by National Institutes of Health
